Non-coding RNAs and Circular RNAs in Tumor Angiogenesis
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Genetics".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 2361
Special Issue Editor
Interests: RNA metabolism; circRNA, translation; molecular biology; angiogenesis; cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) are two types of non-coding RNAs that have been shown to play a role in tumor angiogenesis, the process by which new blood vessels form in tumors to support their growth and spread. LncRNAs are linear RNAs, while circRNAs are covalently closed, continuous RNA circles that do not have a defined 5' or 3' end; both are longer than 200 nucleotides. Even though they are often present in low copy numbers in cells, some are critical gene expression regulators. Both have been found to regulate various pathophysiological cellular processes, including tumor angiogenesis, by acting as epigenetic regulators, transcriptional and post-transcriptional regulators, molecular scaffolds, decoys, miRNA sponges, or even by encoding novel peptides, challenging their “non-coding” quality.
Although lncRNAs and circRNAs have emerged as important regulators of tumor angiogenesis, and their dysregulation is linked to the progression of various types of cancer, the full scale of the molecular mechanisms by which these “non-coding” RNAs regulate tumor angiogenesis is yet to be uncovered, providing novel therapeutic perspectives.
This Special Issue welcomes submissions of original research articles or review articles documenting novel implications of lncRNAs and circRNAs in tumor angiogenesis.
Dr. Éric Lacazette
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lncRNA
- circRNA
- cancer
- tumor angiogenesis
- metastasis
- tumor microenvironment
- EMT
- cancer therapy
- cancer diagnosis
